Understanding Contraindications
A contraindication is a condition or factor that increases the risk of an adverse outcome from a treatment, to the point where that treatment should either be avoided entirely (absolute contraindication) or used only with special precautions and monitoring (relative contraindication).
Ketamine troches have both absolute and relative contraindications. A competent prescribing evaluation identifies these before any prescription is written. Understanding them as a patient helps you have an informed conversation with your provider and recognize if you are being prescribed ketamine without appropriate screening. Knowing the red flags when choosing a provider helps protect you further.
Absolute Contraindications
These are conditions where the risk of harm from ketamine is so high that no reasonable clinical justification overrides it.
Active Psychosis or Schizophrenia Spectrum Disorders
Ketamine is an NMDA receptor antagonist. NMDA hypofunction is a proposed neurobiological mechanism of schizophrenia — this is sometimes called the "ketamine model of psychosis" because ketamine can produce symptoms resembling schizophrenia in healthy individuals. In patients with schizophrenia or other psychotic disorders, ketamine can dramatically exacerbate psychotic symptoms, including hallucinations, delusions, and disorganized thinking.
Active psychosis or a current diagnosis of schizophrenia, schizoaffective disorder, or other primary psychotic disorder is an absolute contraindication to ketamine therapy.
Historical psychosis: A history of a single psychotic episode (such as a brief psychotic disorder or substance-induced psychosis without recurrence) may not be an absolute contraindication, but requires careful clinical assessment and monitoring. This is a relative contraindication requiring case-by-case evaluation.
Uncontrolled Hypertension
Ketamine predictably elevates blood pressure and heart rate. In patients with severe, uncontrolled hypertension (consistent systolic BP >160 mmHg or diastolic >100 mmHg despite treatment), the additional cardiovascular load from ketamine poses serious risks including hypertensive crisis, stroke, and myocardial infarction.
Controlled hypertension (BP well-managed to near-normal with medication) is not a contraindication, though it warrants careful monitoring. It is the uncontrolled state that creates absolute contraindication.
Intracranial Hypertension
Conditions that raise intracranial pressure (ICP) — including severe traumatic brain injury with elevated ICP, active intracranial hemorrhage, or brain tumors with mass effect — are classical contraindications to ketamine because ketamine elevates cerebral metabolic rate and cerebral blood flow, which can worsen elevated ICP.
The historical concern about ICP elevation with ketamine has been somewhat revised in modern anesthesia practice (ketamine use in brain injury has been re-evaluated), but for the standard outpatient therapeutic use, established intracranial hypertension remains a contraindication.
Known Allergy to Ketamine or Troche Excipients
A documented allergic reaction to ketamine itself (extremely rare) or to any troche excipient (PEG, flavoring agents, preservatives) is a contraindication. Patients with known PEG allergy (uncommon but documented) should discuss this with their prescriber and pharmacy — preservative-free, PEG-free formulations may be possible.
Pregnancy
Ketamine crosses the placental barrier and has been detected in fetal tissue at high concentrations in animal models. While ketamine has been used in obstetric anesthesia (the risk is different for brief anesthetic doses than for repeated therapeutic dosing), the repeated sublingual exposure of ketamine therapy poses uncharacterized fetal risk. Pregnancy is a contraindication to elective ketamine troche therapy.
Patients who become pregnant during ketamine therapy should contact their prescriber immediately to discuss discontinuation and transitional management.
Relative Contraindications
These conditions increase risk and require careful evaluation, monitoring, and often modified protocols — but do not absolutely preclude treatment when clinical benefit justifies the risk.
Cardiovascular Disease
Ketamine's cardiovascular effects (BP and HR elevation) are manageable in most patients but require more careful consideration in patients with:
- Coronary artery disease: The increased myocardial oxygen demand from BP and HR elevation can stress ischemic hearts
- History of stroke or TIA: BP elevation increases stroke risk
- Heart failure: Increased cardiac work may not be well-tolerated
- Arrhythmia: Stimulatory effects may trigger or worsen arrhythmias
These patients require cardiology clearance before ketamine therapy, aggressive BP monitoring, and typically lower doses with slower titration.
Bipolar Disorder
As discussed in detail in the bipolar disorder article, ketamine can precipitate manic episodes in bipolar patients. This is a relative contraindication requiring mood stabilizer coverage, careful patient selection (bipolar II patients in stable depressive phase are more reasonable candidates than frequently cycling bipolar I), and enhanced monitoring.
Active Substance Use Disorder
Active addiction to alcohol, opioids, stimulants, or other substances creates several concerns:
- Impaired judgment and consent capacity during active use
- Diversion risk for a Schedule III controlled substance
- Interaction effects with substances being used
- Risk of ketamine becoming a substitute addiction
Active SUD is a relative contraindication requiring addiction medicine assessment. Patients in stable recovery (typically >3 to 6 months) with strong support systems may be considered with enhanced monitoring.
Liver Disease
Ketamine is extensively metabolized in the liver (primarily via CYP3A4 and CYP2B6). Severe hepatic impairment can:
- Reduce clearance, leading to prolonged and more intense effects
- Increase accumulation of ketamine and metabolites
- Reduce production of potentially therapeutic metabolites (norketamine, HNK)
Mild liver disease may require dose reduction; severe liver disease (Child-Pugh Class C) is a strong relative contraindication.
Thyroid Disease
Hyperthyroidism amplifies the sympathomimetic effects of ketamine, potentially producing exaggerated cardiovascular responses. Patients with uncontrolled hyperthyroidism should not receive ketamine; those with well-controlled thyroid disease can be considered with enhanced cardiovascular monitoring.
Significant PTSD With Active Trauma Triggers
This is a nuanced consideration: PTSD is an indication for ketamine therapy, but patients with severe, active trauma triggers who are not currently engaged in trauma-focused therapy may have difficult, re-traumatizing ketamine sessions without adequate processing support. This is not a contraindication per se, but a contraindication to initiating ketamine without concurrent trauma therapy — which providers sometimes frame as a relative contraindication.
Elderly Patients (>65 Years)
Not a contraindication, but a risk modifier. Elderly patients:
- Have higher cardiovascular risk from BP and HR elevation
- May metabolize ketamine more slowly (reduced CYP activity with age)
- Are more sensitive to cognitive effects and fall risk during sessions
- Often take more medications with interaction potential
Elderly patients require more conservative dosing, slower titration, and enhanced monitoring — not exclusion from treatment.
History of Substance Use Without Current Disorder
A past history of alcohol, cannabis, or other substance use disorder in stable, long-term remission is not an absolute contraindication. Risk is elevated compared to never-users, but with appropriate monitoring and clear use boundaries, ketamine therapy can be considered. This is a clinical judgment call made in the context of individual patient assessment.
What to Do If You Have a Potential Contraindication
If you have any condition that might be a contraindication:
- Disclose it fully to your potential prescriber — do not omit it hoping to avoid disqualification
- Request a thorough discussion of how it affects your candidacy
- Seek specialist input if warranted (cardiologist clearance for CV disease, psychiatric consultation for complex psychosis history)
- Consider whether the benefit truly outweighs the risk given your specific history
- Understand that proceeding despite a relative contraindication requires enhanced monitoring and informed consent specific to your risk
Contraindications exist to protect patients, not to withhold beneficial treatments arbitrarily. A thoughtful provider will weigh risk and benefit carefully rather than applying contraindication lists rigidly.
Key Takeaways
- Absolute contraindications include active psychosis, uncontrolled hypertension, intracranial hypertension, known allergy, and pregnancy.
- Relative contraindications include cardiovascular disease, bipolar disorder, active substance use disorder, liver disease, and thyroid disease.
- Relative contraindications require case-by-case clinical assessment, not automatic exclusion.
- Always disclose potential contraindications fully to your prescriber.
- Proceeding despite relative contraindications requires enhanced monitoring and explicit informed consent.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- SAMHSA: National Helpline — Substance Abuse and Mental Health Services Administration free treatment referral and information service
Share